Combination Chemotherapy in Treating Older Patients With Solid Tumour,
NCT ID: NCT00664911
Last Updated: 2013-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
516 participants
INTERVENTIONAL
2008-03-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying how well combination chemotherapy works in treating older patients with solid tumour.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* To determine a prognostic scale of the feasibility of chemotherapy (at least two-thirds of the dose intensity usually administered) in patients aged 75 years or older with solid tumour.
Secondary
* To evaluate the efficacy, in terms of clinical and/or biological response, of treatments administered.
* To evaluate the incidence of severe (grade 3-4) toxicity.
OUTLINE: This is a multicenter study. Patients receive one of the following regimens according to cancer diagnosis and principal investigator preference. All regimens last 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chemotherapy
chemotherapy regimen
chemotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
chemotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed solid tumour regardless of localization or stage
PATIENT CHARACTERISTICS:
* \> or = 75 years
* patient planned to receive \> or = 2/3 of standard dose of the first cycle
PRIOR CONCURRENT THERAPY:
Chemonaive patient.
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GERCOR - Multidisciplinary Oncology Cooperative Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth Carola, MD
Role: STUDY_CHAIR
C.H. Senlis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Radiotherapie Oncologie Moyenne Garonne
Agen, , France
Centre Hospitalier de Castelluccio
Ajaccio, , France
Centre Hospitalier d'Ardeche Meridionale
Aubenas, , France
Centre Hospitalier d'Auxerre
Auxerre, , France
Institut Sainte Catherine
Avignon, , France
Hopital Duffaut
Avignon, , France
Centre Hospitalier de Beauvais
Beauvais, , France
Clinique des Cedres
Cornebarrieu, , France
Centre Medico-Chirurgical et Obstetrique d'Evry
Évry, , France
Hopital Clarac
Fort de France Cedex, , France
Centre Hospitalier Intercommunal des Alpes du Sud
Gap, , France
Centre Hospitalier de Lagny
Lagny-sur-Marne, , France
Centre Hospitalier St. Joseph St. Luc
Lyon, , France
Hopital Prive Jean Mermoz
Lyon, , France
Centre Hospitalier Chanaux
Mâcon, , France
Centre Hospitalier de Montelimar
Montélimar, , France
Hopital Bichat - Claude Bernard
Paris, , France
Hopital de la Croix St. Simon
Paris, , France
Hopital Saint Antoine
Paris, , France
Hopital Tenon
Paris, , France
Hopital Rene Dubos
Pontoise, , France
Institut Jean Godinot
Reims, , France
Centre Hospitalier Prive Saint-Gregoire
Saint-Grégoire, , France
Centre Hospitalier de Saint-Quentin
Saint-Quentin, , France
Centre Hospitalier de Semur en Auxois
Semur-en-Auxois, , France
C.H. Senlis
Senlis, , France
Hopital Foch
Suresnes, , France
Centre hospitalier de Tonnerre
Tonnerre, , France
Centre Hospitalier Villeneuve Saint Georges
Villeneuve-Saint-Georges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GERCOR-OLD
Identifier Type: -
Identifier Source: secondary_id
EudraCT-2007004103-36
Identifier Type: -
Identifier Source: secondary_id
CDR0000593133
Identifier Type: -
Identifier Source: org_study_id